An open-label trial used VEGF165 gene transfer as an intra-muscular injection in the ischemic thigh in patients with critical ischemia with/without DM
51 MugfordS
It involved ten women and nine men aged 55-71 who received nightly injections of placebo for four weeks, followed by 10mcg/kg of sermorelin for 16 weeks
Hospital La Paz Institute for Health Research IdiPAZ (La Paz University Hospital Universidad Autnoma de Madrid), Madrid, Spain, 2 Stroke Code Coordination Center, Servicio de Emergencias Mdicas SUMMA-112, Madrid, Spain, 3 Department of Neurology, Hospital Universitario Clnico San Carlos, Universidad Complutense de Madrid, Madrid, Spain, 4 Department of Neurology and Stroke Center, Hospital Universitario 12 de Octubre, Instituto de Investigacin Hospital 12 de Octubre (i+12), Madrid, Spain, 5 Department of Neurology, University Hospital Puerta de Hierro, Universidad Autonoma de Madrid, Madrid, Spain Background and Aims: In our stroke network, direct transfer to mechanical thrombectomy (MT) center (MT-C) instead of nearest non-MT-capable stroke unit (NSU) is determined by an M-DIRECT score 2
Journal of Chromatography A, 1265, 57-69